Clinical trials
Withdrawn Phase 2 Purpura, Thrombocytopenic, Idiopathic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Kezar Life Sciences, Inc. | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Peking University People's Hospital | 1 |
| Shandong University | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 8 |
| Anemia | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| COVID-19 | 1 |
| Graft vs Host Disease | 1 |
| Hematologic Diseases | 1 |
| Hemolysis | 1 |
| Leukemia | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.